Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2026-04-11 @ 7:06 AM
Study NCT ID:
NCT06667050
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-10-31
First Post:
2024-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Sponsor:
West China Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
WCH241260
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None